Ironwood Pharmaceuticals reported $68.84M in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Akebia Therapeutics AKBA:US USD -38570000 96.43M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
Astellas Pharma 4503:JP JPY 108.16B 38.67B
AstraZeneca AZN:LN USD 3.6B 404M
Astrazeneca AZN:US USD 3.6B 404M
Bluebird Bio BLUE:US USD -85093000 14.32M
Charles River Laboratories CRL:US USD 225.58M 38.25M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
Exact Sciences EXAS:US USD -83543000 17.59M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Ironwood Pharmaceuticals IRWD:US USD 68.84M 12.82M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Macrogenics MGNX:US USD -22111000 16.82M
Moderna Inc MRNA:US USD 1.28B 1.24B
Myriad Genetics MYGN:US USD -31900000 27.1M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Takeda 4502:JP JPY 272.27B 36.53B
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
YTE INCY:US USD 134.94M 141.85M